Le Calvé, B., Rynkowski, M., Le Mercier, M., Bruyère, C., Lonez, C., Gras, T., . . . Lefranc, F. (2010). Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression. Neoplasia Press Inc.
Chicago Stili AlıntıLe Calvé, Benjamin, et al. Long-term In Vitro Treatment of Human Glioblastoma Cells With Temozolomide Increases Resistance In Vivo Through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression. Neoplasia Press Inc, 2010.
MLA AlıntıLe Calvé, Benjamin, et al. Long-term In Vitro Treatment of Human Glioblastoma Cells With Temozolomide Increases Resistance In Vivo Through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression. Neoplasia Press Inc, 2010.